Home/ Supplements/ Vitamin K/ Vitamin K 100 mcg

Vitamin K 100 mcg

product on market Tablet or Pill GNC Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin K and calcium are utilized to support bone health and blood coagulation. While research on these nutrients is extensive, the evidence coverage for this specific formulation is limited. Both ingredients are generally recognized as safe for most users.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Single Vitamin and Mineral
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg (83% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)
Calcium
50 mg (4% DV)

Other Ingredients

Dicalcium Phosphate Microcrystalline Cellulose Mannitol Stearic Acid Magnesium Stearate Croscarmellose Sodium
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take one tablet daily.

Warnings & Precautions

Keep out of reach of children.

Warning: Do not use if pregnant, nursing or are allergic or contraindicated to aspirin. If you are taking aspirin or blood thinning or other medication, consult your healthcare professional before using this product.

Discontinue use two weeks prior surgery, or if upset stomach occurs.

Formulation Notes

Helps the body transport calcium Involved in bone matrix formation

Vitamin K is necessary for blood clotting.

Potency verified by GNC procedure #5024. Conforms to USP <2091> for weight. Meets USP <2040> disintegration.

Ko (Kosher)

Additional Information

Store in a cool, dry place.

180-Day supply

Metadata

Product Details

UPC / SKU0 48107 20439 6
DSLD Entry Date2020-05-22
Product TypeSingle Vitamin and Mineral
FormTablet or Pill
BrandGNC
DSLD ID219240
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.